Open Access
EPJ Nonlinear Biomed Phys
Volume 4, Number 1, December 2016
Article Number 1
Number of page(s) 24
Published online 27 January 2016
  1. Strumpher J, Jacobsohn E. Pulmonary hypertension and right ventricular dysfunction: Physiology and perioperative management. J Cardiothorac Vasc Anesth. 2011; 25(4):687–704.
  2. Montani D, Sitbon O, Fadel E, Datevelle P, Nunes H, Lebrec D, et al. Hypertension artérielle pulmonaire. EMC-Pneumologie. 2004; 1:46–68.
  3. von Romberg E. Über sklerose der lungenarterie. Deutsch Archiv für klinische Medizin. 1891; 48:197–206.
  4. Lourenço AP, Fontoura D, Henriques-Coelho T, Leite-Moreira AF. Current pathophysiological concepts and amangement of pulmonary hypertension. Int J Cardiol. 2012; 155:350–61.
  5. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle–pulmonary circulation unit : State of the art and clinical and reasearch implications. Circulation. 2009; 120:992–1007.
  6. Nichols WW, O’Rourke MF. McDonald’s Blood Flow in Arteries : Theoretical, Experimental and Clinical Principles. 3rd (ed), Edward Arnold. London; 1990.
  7. Hales S. Statistical Essays : Hæmastaticks vol. 2. Innys and Manby. Rome; 1733.
  8. Weber EH. Comments on Anatomy and Physiology. C. F. Koehler: Leipzig; 1834.
  9. Westerhof N, Lankhaar J-W, Westerhof BE. The arterial windkessel. Med Biol Eng Comput. 2009;47:131–141.
  10. MK Sharp, WL Capper. Development of hydraulic model of the human systemic circulation. ASAIO J. 1999; 45:334–338.
  11. De Pater L, Van Den Berg JW. An electrical analogue of the entire human circulatory system. Med Electron Biol Eng. 1964; 2:161–166.
  12. žácek M, Krause E. Numerical simulation of the blood flow in the human cardiovascular system. J Biomech. 1996; 29:13–20.
  13. Korakianitis T, Shi Y. A concentrated paramter model for the human cardiovascular system including heart valve dynamics and atrioventricular interaction. Med Eng Phys. 2006; 28:613–28.
  14. Fernandez de Canete J, del Saz-Orozco P, Moreno-Boza D, Duran-Venegas E. Object-oriented modeling and simulation of the closed loop cardiovascular system by using simscape. Comput Biol Med. 2013; 43:323–333.
  15. Smith BW, Andreassen S, Shaw GM, Jensen PL, Rees SE, Chase JG. Simulation of cardiovascular system diseases by including the autonomic nervous system into a minimal model. Comput Methods Programs Biomed. 2007; 86:153–60.
  16. Guyton AC, Coleman TG, Cowley AW, Liard J-F, Norman RA, Davis Manning R. Systems analysis of arterial pressure regulation and hypertension. Ann Biomed Eng. 1972; 1:254–81.
  17. Guyton AC, Jones CE, Coleman TG. Circulatory Physiology: Cardiac Output and Its Regulation. Saunders; 1973.
  18. Sagawa K. Critique of a large-scale organ system model: Guytonian cardiovascular model. Ann Biomed Eng. 1975; 3:386–400.
  19. Brown SP, Miller WC, Eason JM. Exercise Physiology. Lippincott Williams and Wilkins. Philadelphia; 2006.
  20. Kurl S, Laukkanen JA, Rauramaa R, Lakka TA, Sivenius J, Salonen JT. Systolic blood pressure response to exercise stress test and risk of stroke. Stroke. 2001; 32:2036–41.
  21. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healty subjects : a systematic review. Eur Respir J. 2009; 34:888–94.
  22. Matsumoto H. Measurement of instantaneous right ventricular compliance by phasic tricuspid flow velocity. Pediatr Cardiol. 1986; 7:155–6.
  23. Hilde JM, Skjørten I, Grøtta OJ, Hansteen V, Melsom MN, Hisdal J, et al.Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. J Am Coll Cardiol. 2013; 62:1103–11.
  24. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies. Aliment Pharmacol Ther. 2010; 128:191–227.
  25. Pons-Lladó G, Ballester M, Borrás X, Carreras F, Carrió I, Lóprez-Contreras J, et al. Myocardial cell damage in human hypertension. J Am Coll Cardiol. 2000; 36(7):2198–203.
  26. Schlosser T, Pagonidis K, Herborn CU, Hunold P, Waltering K-U, Lauenstein TC, et al. Assessment of left ventricular parameters using 16-mdct and new software for endocardial and epicardial border delineation. Am J Roentgenol. 2005; 184(3):765–73.
  27. Kovalova S, Necas J, Vespalec J. What is a “normal” right ventricle?. Eur J Echocardiogr. 2006; 7:293–7.
  28. Rausch MK, Dam A, Göktepe S, Abilez OJ, Kuhl E. Computational modeling of growth Systemic and pulmonary hypertension in the heart. Biomech Model Mechanobiol. 2011; 10(6):799–811.
  29. Minami S, Onodera T, Okazaki F, Miyazaki H, Ohsawa S, Mochizuki S. Myocyte morphological characteristics differ between the phases of pulmonary hypertension-induced ventricular hypertrophy and failure. Int Heart J. 2006; 47:629–37.
  30. Lumens J, Delhaas T. Cardiovascular modeling in pulmonary arterial hypertension: Focus on mechanisms and treatment of right heart failure using the CircAdapt model. Am J Cardiol. 2012; 110:39S–48S.
  31. McLaughlin VV, McGoon MD. Contemporary reviews in cardiovascular medicine: Pulmonary Arterial Hypertension. Circulation. 2006; 114:1417–31.
  32. Osenkranz S, Bonderman D, Buerke M, et al. Pulmonary hypertension due to left heart disease: updated recommendations of the Cologne Consensus Conference. Int J Cardiol. 2011; 154:S34–S44.
  33. Georgiopoulou VV, Kalogeropoulos AP, Borlaug BA, Gheorghiade M, Butler J. Left ventricular dysfunction with Pulmonary Hypertension. Part 1, epidemiology, pathophysiology, and definitions, Circ Heart Fail. 2013; 6:344–54.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.